F2G Ltd, a UK-based antifungal drug discovery company, has hired Ralf Schmid as its chief financial officer. He joins F2G from Nabriva Therapeutics AG in Vienna where he served on the management board from the company’s inception in 2006.
In his role as Nabriva’s chief financial and chief operating officer, Mr Schmid helped take the company public on the US Nasdaq over-the-counter market in September 2015. Mr Schmid holds a master’s degree in finance and economics from Otto-Friedrich-Universität in Bamberg, Germany.
The appointment was announced 11 July 2016
Copyright 2016 Evernow Publishing Ltd